Intrahepatic cholangiocellular carcinoma (review)
- Authors: Zharikov Y.O1, Shevchenko TV1, Zhao AV1
-
Affiliations:
- A.V.Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 2 (2015)
- Pages: 18-25
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/26994
- ID: 26994
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yu O Zharikov
A.V.Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federation
Email: deadmaster_89@mail.ru
аспирант отд. абдоминальной хирургии, отд-ния хирургии печени и поджелудочной железы ФГБУ Институт хирургии им. А.В.Вишневского 117997, Russian Federation, Moscow, ul. Bol'shaia Serpukhovskaia, d. 27
T V Shevchenko
A.V.Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federationканд. мед. наук, ст. науч. сотр. отд. абдоминальной хирургии, отд-ния хирургии печени и поджелудочной железы ФГБУ Институт хирургии им. А.В.Вишневского 117997, Russian Federation, Moscow, ul. Bol'shaia Serpukhovskaia, d. 27
A V Zhao
A.V.Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federationд-р мед. наук, проф., зам. дир. по научной работе ФГБУ Институт хирургии им. А.В.Вишневского 117997, Russian Federation, Moscow, ul. Bol'shaia Serpukhovskaia, d. 27
References
- Имянитов Е.Н. Эпидемиология и биология опухолей кожи. Практ. онкология. 2012; 13 (2): 61-8.
- Майстренко Н.А., Шейко С.Б., Алентьев А.В., Азимов Ф.Х. Холангиоцеллюлярный рак (особенности диагностики и лечения). Практ. онкология. 2008; 9 (4): 229-36.
- American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
- Anderson М.А, Appalaneni V, Ben-Menachem T et al. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. Gastrointest Endosc 2013; 77 (2): 167-74. doi: 10.1016/j.gie.2012.09.029.
- Ariizumi Sh, Kotera Yo, Katagiri S, Nakano M et al. Long - term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy. Ann Surg Oncol 2014; 21: 451-8. doi: 10.1245/s10434- 014-3582-0.
- Blechacz B, Komuta M, Roskams T, Gores G.J. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8 (9): 512-22. doi: 10.1038/nrgastro.2011.131.
- Bloom C.M, Langer B, Wilson S.R. Role of US in the detection, characterization, and staging of cholangiocarcinoma. Radiographics 1999; 19 (5): 1199-218.
- Cardinale V, Bragazzi M.C, Carpino G et al. Cholangiocarcinoma: increasing burden of classifications. Hepatobiliary Surgery Nutrition 2013; 2 (5): 272-80. doi: 10.3978/j.issn.2304-3881.2013.10.02.
- Comoglio P.M, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008; 7 (6): 504-16. doi: 10.1038/nrd2530.
- De Oliveira M.L. Liver transplantation for cholangiocarcinoma: current best practice. Curr Opin Org Transplant 2014; 19 (3): 245-52. doi: 10.1097/MOT.0000000000000087.
- Farges O, Fuks D, Le Treut Y.P et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer 2011; 117 (10): 2170-7. doi: 10.1002/cncr.25712.
- Guglielmi A, Ruzzenente A, Campagnaro T et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009; 33 (6): 1247-54. doi: 10.1007/s00268-009-9970-0.
- Kiefer M.V, Albert M, Mc Nally M et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer 2011; 117 (7): 1498-505. doi: 10.1002/cncr.25625.
- Kloeckner R, Ruckes C, Kronfeld K et al. Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial. Trials 2014; 15 (1): 311. doi: 10.1186/1745-6215-15-311.
- Komuta M, Spee B, Borght S.V et al. Clinicopathological Study on Cholangiolocellular Carcinoma Suggesting Hepatic Progenitor Cell Origin. Hepatology 2008; 47 (5): 1544-56. doi: 10.1002/hep.22238.
- Lai G.H, Radaeva S, Nakamura T et al. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated «intestinaltype» biliary cancer chemically induced in rat liver. Hepatology 2000; 31 (6): 1257-65.
- Makuuchi M, Torzilli G, Minagawa M et al. Accurate preoperative evaluation of liver mass lesions without fine - needle biopsy. Hepatology 1999; 30 (4): 889-93.
- Mavros M.N, Economopoulos K.P, Alexiou V.G, Pawlik T.M. Treatment and Prognosis for Patients with Intrahepatic Cholangiocarcinoma: Systematic Review and Meta - analysis. JAMA Surg 2014; 149 (6): 565-74. doi: 10.1001/jamasurg.2013.5137.
- Miyamoto M, Ojima H, Iwasaki M et al. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma. Br J Cancer 2011; 105 (1): 131-8. doi: 10.1038/bjc.2011.199.
- Nakanuma Y, Tsutsui A, Ren X.S. What Are the Precursor and Early Lesions of Peripheral Intrahepatic Cholangiocarcinoma? Int J Hepatol 2014; 2014: 805973. doi: 10.1155/2014/805973.
- Padden J, Megger D.A, Bracht T et al. Identification of Novel Biomarker Candidates for the Immunohistochemical Diagnosis of Cholangiocellular Carcinoma. Mol Cell Proteomics 2014; 13 (10): 2661-72. doi: 10.1074/mcp.M113.034942.
- Patel T. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol 2014; 49 (2): 165-72. doi: 10.1007/s00535-013-0894-y.
- Rizvi S, Gores G.J. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 2013; 145 (6): 1215-29. doi: 10.1053/j.gastro.2013.10.013.
- Sato Y, Harada K, Sasaki M, Nakanuma Y. Clinicopathological significance of S100 protein expression in cholangiocarcinoma. J Gastroenterol Hepatol 2013; 28 (8): 1422-9. doi: 10.1111/ jgh.12247.
- Shaib Y, El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-25.
- Sia D, Hoshida Y, Villanueva A et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013; 144 (4): 829-40. doi: 10.1053/j.gastro.2013.01.001.
- Sia D, Tovar V, Moeini A, Llovet J.M. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene 2013; 32 (41): 4861-70. doi: 10.1038/onc.2012.617.
- Vilana R, Forner A, Bianchi L et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast - enhanced ultrasound. Hepatology 2010; 51 (6): 2020-9. doi: 10.1002/hep.23600.
- Witjes C.D, Karim-Kos H.E, Visser O et al. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB (Oxford) 2012; 14 (11): 777-81. doi: 10.1111/j.1477- 2574.2012.00536.x.
- Zechlinski J.J, Rilling W.S. Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. Semin Intervent Radiol 2013; 30 (1): 21-7. doi: 10.1055/s-0033-1333650.
- Zhang L, Frank R, Furth E.E et al. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Experiment Hematol Oncol 2014; 3: 12. doi: 10.1186/2162-3619-3-12.
- Zhang W, Yan L. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointestinal Pathophysiol 2014; 5 (3): 344-54. doi: 10.4291/wjgp.v5.i3.344.